Extent Of DXM Abuse May Not Support Scheduling
This article was originally published in The Tan Sheet
Executive Summary
Dextromethorphan abuse is increasing slightly, but the problem is not widespread, according to FDA. One expert notes the extent might not justify scheduling the cough suppressant as a controlled substance